Briacell Therap (BCTX) Competitors $0.82 +0.05 (+6.49%) Closing price 04:00 PM EasternExtended Trading$0.83 +0.01 (+1.33%) As of 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BCTX vs. PLRX, ZURA, EPIX, QNCX, SRZN, INCR, IMMX, ABOS, IMUX, and GNTAShould you be buying Briacell Therap stock or one of its competitors? The main competitors of Briacell Therap include Pliant Therapeutics (PLRX), Zura Bio (ZURA), ESSA Pharma (EPIX), Quince Therapeutics (QNCX), Surrozen (SRZN), InterCure (INCR), Immix Biopharma (IMMX), Acumen Pharmaceuticals (ABOS), Immunic (IMUX), and Genenta Science (GNTA). These companies are all part of the "pharmaceutical products" industry. Briacell Therap vs. Its Competitors Pliant Therapeutics Zura Bio ESSA Pharma Quince Therapeutics Surrozen InterCure Immix Biopharma Acumen Pharmaceuticals Immunic Genenta Science Pliant Therapeutics (NASDAQ:PLRX) and Briacell Therap (NASDAQ:BCTX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership. Do analysts rate PLRX or BCTX? Pliant Therapeutics presently has a consensus price target of $13.31, suggesting a potential upside of 893.47%. Briacell Therap has a consensus price target of $32.00, suggesting a potential upside of 3,792.47%. Given Briacell Therap's stronger consensus rating and higher possible upside, analysts plainly believe Briacell Therap is more favorable than Pliant Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pliant Therapeutics 0 Sell rating(s) 12 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Briacell Therap 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is PLRX or BCTX more profitable? Pliant Therapeutics' return on equity of -67.56% beat Briacell Therap's return on equity.Company Net Margins Return on Equity Return on Assets Pliant TherapeuticsN/A -67.56% -52.54% Briacell Therap N/A -479.97%-182.26% Which has more volatility and risk, PLRX or BCTX? Pliant Therapeutics has a beta of 1.3, indicating that its stock price is 30% more volatile than the S&P 500. Comparatively, Briacell Therap has a beta of 1.27, indicating that its stock price is 27% more volatile than the S&P 500. Does the media refer more to PLRX or BCTX? In the previous week, Briacell Therap had 5 more articles in the media than Pliant Therapeutics. MarketBeat recorded 7 mentions for Briacell Therap and 2 mentions for Pliant Therapeutics. Pliant Therapeutics' average media sentiment score of 1.81 beat Briacell Therap's score of 0.27 indicating that Pliant Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pliant Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Briacell Therap 0 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders have more ownership in PLRX or BCTX? 97.3% of Pliant Therapeutics shares are held by institutional investors. Comparatively, 15.4% of Briacell Therap shares are held by institutional investors. 6.4% of Pliant Therapeutics shares are held by company insiders. Comparatively, 5.7% of Briacell Therap shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has higher valuation and earnings, PLRX or BCTX? Briacell Therap has lower revenue, but higher earnings than Pliant Therapeutics. Pliant Therapeutics is trading at a lower price-to-earnings ratio than Briacell Therap, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPliant Therapeutics$1.58M52.06-$210.30M-$3.61-0.37Briacell TherapN/AN/A-$4.79M-$8.32-0.10 SummaryPliant Therapeutics beats Briacell Therap on 8 of the 14 factors compared between the two stocks. Get Briacell Therap News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BCTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BCTX vs. The Competition Export to ExcelMetricBriacell TherapMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.57M$2.93B$5.57B$9.31BDividend YieldN/A2.43%4.23%4.03%P/E Ratio-0.1020.4928.6119.73Price / SalesN/A267.08411.31174.27Price / CashN/A43.1536.0257.96Price / Book-0.377.768.235.67Net Income-$4.79M-$55.11M$3.23B$257.79M7 Day Performance-61.04%0.95%-0.01%0.52%1 Month Performance-73.98%8.44%5.60%8.84%1 Year Performance-94.40%-2.38%26.54%14.18% Briacell Therap Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BCTXBriacell Therap1.8756 of 5 stars$0.82+6.5%$32.00+3,792.5%-94.5%$5.57MN/A-0.108News CoverageHigh Trading VolumePLRXPliant Therapeutics4.4588 of 5 stars$1.18-6.3%$13.31+1,028.2%-89.5%$77.35M$1.58M-0.3390ZURAZura Bio3.075 of 5 stars$1.10-2.7%$14.33+1,203.0%-64.8%$77.26MN/A-1.573Positive NewsGap UpEPIXESSA Pharma1.0573 of 5 stars$1.70-2.3%$2.00+17.6%-66.7%$77.24MN/A-2.7050QNCXQuince Therapeutics3.0548 of 5 stars$1.63+1.2%$8.00+390.8%+130.7%$73.21MN/A-1.1760News CoverageSRZNSurrozen2.7519 of 5 stars$8.35-0.1%$38.50+361.1%-10.0%$71.58M$10.65M-0.3380Gap UpINCRInterCure0.6724 of 5 stars$1.50-3.8%N/A-37.4%$71.09M$238.85M0.00350News CoverageHigh Trading VolumeIMMXImmix Biopharma3.5672 of 5 stars$2.62+2.7%$7.00+167.2%+35.3%$71.09MN/A-3.749ABOSAcumen Pharmaceuticals3.0034 of 5 stars$1.16flat$6.33+446.0%-54.7%$70.26MN/A-0.6020News CoverageIMUXImmunic2.4802 of 5 stars$0.77+5.2%$11.60+1,416.3%-38.7%$69.68MN/A-0.6270GNTAGenenta Science2.5999 of 5 stars$3.98+4.7%$25.00+528.1%+10.0%$69.50MN/A0.007Gap Up Related Companies and Tools Related Companies PLRX Alternatives ZURA Alternatives EPIX Alternatives QNCX Alternatives SRZN Alternatives INCR Alternatives IMMX Alternatives ABOS Alternatives IMUX Alternatives GNTA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BCTX) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredBuffett’s Little-Known Succession PlanYou could miss out on millions buying a house - even if prices rise Joel Litman is a millionaire member of ...Altimetry | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Briacell Therap Please log in to your account or sign up in order to add this asset to your watchlist. Share Briacell Therap With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCTX Stock Alerts